Clinical Trial Update: The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of CUNOX® in adults with moderate to severe glabellar lines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• CUNOX®

Snippet

Sponsor: Medy-Tox | Conditions: Glabellar Frown Lines | Phase 3 | Status: COMPLETED